Generic Sterile Injectable Market

Global Generic Sterile Injectable Market Size, Share & Trends Analysis, By Drug Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulins, and Others), By Therapeutic Application (Cancer, Diabetes, CVD, Central Nervous System, Infectious Diseases, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) (Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025545 | Category : Pharmaceuticals | Delivery Format: /

The global generic sterile injectable market is expected to grow at a significant CAGR during the forecast period (2021-2027).  The generic sterile injectable is the biologics that are used to treat a variety of diseases and have the same active ingredients as branded versions, however, the inactive contents of the medications can differ. The major factors influencing the growth of the market is the rising prevalence of chronic diseases and a rapidly ageing population that is especially susceptible to chronic diseases. The rising prevalence of chronic diseases such as cancer, COPD, and diabetes, as well as the resulting increase in demand for newer generic injectables in various European countries, is propelling the growth of the market. 

According to the World Health Organization (WHO), the mortality rate of COPD for men and women is about 18 per 1,00,000 inhabitants per year, in Europe. In the same vein, the countries in Europe are experiencing a substantial rise in diabetes cases. According to the WHO, in 2019, Germany had the highest prevalence of diabetes in Europe among the adult population with 15.3% living with diabetes in 2019, Portugal followed with the second-largest share of 14.2%. On the other hand, Ireland has the lowest prevalence of diabetes in Europe at 4.4%. Hence, the rising prevalence of chronic disease is driving the market growth. However, the US FDA has strict rules such as monitoring flexible intravenous (IV) solution bags for microscopic punctures or holes on the surface of the bag during labelling and packaging to minimise microscopic faults that may result in microbial contamination. 

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape: Baxter International Inc., Sanofi S.A., and Pfizer Inc., among others. 

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Generic Sterile Injectable Market Report by Segment

By Drug Type  

Monoclonal Antibodies

Cytokines

Insulin

Peptide Hormones

Vaccines

Immunoglobulins

Others (Blood Factors and Peptide Antibiotics)

By Therapeutic Application

Cancer

Diabetes

CVD

Central Nervous System

Infectious Diseases

Others 

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Global Generic Sterile Injectable Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World